Parexel, a global clinical development partner to the world’s life sciences industry, has acquired Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform. The acquisition provides an integrated PV platform that leverages intelligent automation and AI to accelerate end-to-end Patient Safety & PV processes, deliver first-time quality and enhance compliance. The technology platform is system-agnostic and integrates with any safety database – allowing cust...